Matsuo I, Omagari K, Ikuno N, Kinoshita H, Onizuka Y, Itsuno M, Nakayama T, Kohno S
Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
J Gastroenterol. 1997 Aug;32(4):533-7. doi: 10.1007/BF02934095.
A rare case of malignant lymphoma of the stomach after treatment for hepatocellular carcinoma (HCC) is reported. A 72-year old man presented with a large mass on the right hypochondrium, which was diagnosed as HCC associated with chronic hepatitis C with cirrhosis. The inoperable tumor was treated conservatively with cisplatin, etoposide, carboplatin, and Lipiodol infused into the hepatic artery, together with transcatheter arterial embolization. The patient presented 38 months later with features suggestive of gastric ulceration. Endoscopy and histological examination of biopsy material confirmed the presence of malignant lymphoma of the stomach. He ultimately died as a result of hepatic failure. The clinical presentation suggests that gastric lymphoma was possibly related to the lymphotropic effect of hepatitis C virus (HCV) and exacerbated by intraarterial injection of the cytotoxic drugs.
报告了1例肝细胞癌(HCC)治疗后发生胃恶性淋巴瘤的罕见病例。一名72岁男性患者右季肋部出现巨大肿块,诊断为与丙型肝炎相关的HCC合并肝硬化。无法手术的肿瘤采用顺铂、依托泊苷、卡铂和碘油经肝动脉注入,并联合经导管动脉栓塞进行保守治疗。38个月后,患者出现提示胃溃疡的症状。胃镜检查和活检材料的组织学检查证实存在胃恶性淋巴瘤。他最终因肝衰竭死亡。临床表现提示胃淋巴瘤可能与丙型肝炎病毒(HCV)的亲淋巴作用有关,并因动脉内注射细胞毒性药物而加重。